Search
Total Count 95

JAMJOOM PHARMA - Latest News

United Securities issues Q1 2025 earnings forecast

Argaam Special 06/04/2025

Al Rajhi Capital sets Jamjoom Pharma rating, TP

Argaam 08/03/2025

Jamjoom Pharma sales rise 19% in Saudi Arabia, eyes expansion: CEO

Argaam Special 06/03/2025

Jamjoom Pharma 2024 revenue growth reflects operational improvements: CEO

Argaam 26/02/2025

Jamjoom Pharma to distribute 14.6% dividend for H2 2024

Argaam 25/02/2025

Jamjoom Pharma provides SAR 27.1M guarantee to JV in Algeria

Argaam 11/02/2025

Jamjoom Pharma provides SAR 17.7M guarantee for Algeria joint venture

Argaam 02/02/2025

Jamjoom Pharma Q4 2024: What are analysts predicting?

Argaam Special 30/01/2025

Ubhar Capital initiates coverage of Jamjoom Pharma, sets rating, TP

Argaam 25/01/2025

SNB Capital sets Q4 2024 earnings estimates

Argaam Special 12/01/2025

Osool & Bakheet previews Q4 2024 earnings estimates

Argaam Special 12/01/2025

United Securities issues Q4 2024 earnings forecast

Argaam 09/01/2025

GIB Capital issues Q4 2024 earnings estimates

Argaam 06/01/2025

Al Rajhi Capital issues Q4 2024 profit forecasts for TASI-listed firms

Argaam Special 02/01/2025

SNB Capital forecasts Tadawul earnings to rise 8% in 2025

Argaam 01/01/2025

Analyst ratings, average TP for Jamjoom Pharma post-Q3 2024

Argaam Special 23/12/2024

Jamjoom Pharma maintains 2024 guidance

Argaam Special 27/10/2024

What do analysts expect from Jamjoom Pharma's Q3 2024 results?

Argaam Special 24/10/2024

Jamjoom Pharma plans to disclose Q3 2024 financials on Oct. 27

Argaam 10/10/2024

GIB Capital's forecast on Q3 2024 earnings

Argaam Special 10/10/2024

Osool & Bakheet previews Q3 2024 earnings estimates

Argaam Special 08/10/2024

Al Rajhi Capital issues Q3 2024 earnings forecasts for more Tadawul-listed firms

Argaam 07/10/2024

United Securities: As earnings loom, what to expect in Q3 2024?

Argaam 06/10/2024

Key events forecast to impact Saudi-listed firms’ earnings in Q3 2024

Argaam Special 06/10/2024

SNB Capital initiates coverage on Jamjoom Pharma, sets TP

Argaam 15/09/2024

How analysts rated Jamjoom Pharma after Q2 results?

Argaam Special 11/09/2024

Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital

ِArgaam 09/09/2024

FTSE Russell announces periodic changes to Saudi market

Argaam 24/08/2024

Here is a look at stocks, funds with ex-dates today

Argaam Special 15/08/2024

United Securities says Jamjoom Pharma’s net profit beats expectations

Argaam 12/08/2024

Jamjoom Pharma focuses on portfolio optimization, ups forecast for H2 growth: CEO

Argaam Special 12/08/2024

Jamjoom Pharma board plans 16% cash dividend for H1 2024

Argaam 06/08/2024

Analyst forecasts on Jamjoom Pharma Q2 2024 profit

Argaam Special 05/08/2024

Jamjoom Pharma to disclose Q2 2024 financials on Aug. 6

Argaam 18/07/2024

United Securities issues Q2 earnings estimates

Argaam 16/07/2024

Osool & Bakheet issues Q2 2024 earnings forecast

Argaam 09/07/2024

Jamjoom Pharma provides corporate guarantee to Algeria JV

Argaam 08/07/2024

GIB Capital previews Q2 2024 earnings

Argaam 07/07/2024

Al Rajhi Capital issues Q2 2024 profit forecasts

Argaam 04/07/2024

Key events likely to impact Saudi-listed firms’ earnings in Q2 2024

Argaam Special 04/07/2024

Jamjoom Pharma shareholders approve 15% dividend for H2 2023

Argaam 05/06/2024

Tadawul: Bahri, Jamjoom Pharma go ex-dividend today

Argaam Special 04/06/2024

United Securities sets rating, TP for Jamjoom Pharma

Argaam 19/05/2024

Jamjoom Pharma shareholders to vote on 15% dividend for H2 2023 on June 4

Argaam 14/05/2024

Jamjoom Pharma boosts presence in key markets, ramp up production: CEO

Argaam Special 13/05/2024

Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023

Argaam Special 21/04/2024

Osool & Bakheet issues Q1 2024 earnings forecast

Argaam 20/04/2024

Highest-paid executives, board members of Saudi-listed firms in 2023

Argaam Special 16/04/2024

GIB Capital previews Q1 2024 earnings

Argaam 14/04/2024

Al Rajhi Capital issues Q1 profit forecasts for TASI-listed firms

Argaam 06/04/2024

Jamjoom Pharma board proposes 15% dividend for H2 2023

Argaam 04/04/2024

Jamjoom Pharma's 2023 net profit exceeds estimates: United Securities

Argaam 27/03/2024

Jamjoom Pharma expects up to 15% revenue growth over next 2 years, plans expansion

Argaam 25/03/2024

Jamjoom Pharma to disclose 2023 financials on March 25

Argaam 19/03/2024

Jamjoom Pharma seen to post profit growth in Q4 2023

Argaam Special 20/02/2024

Jamjoom Pharma signs contract with LCGPA to localize drug production

Argaam 30/01/2024

LCGPA signs 4 agreements to localize pharma industry

Argaam 29/01/2024

Jamjoom Pharma gets SFDA approval to register eye drop facility in Jeddah

Argaam 28/01/2024

Jamjoom Pharma provides SAR 17.7M corporate guarantee to Algeria JV

Argaam 21/01/2024

GIB Capital previews Q4 2023 earnings

Argaam Special 10/01/2024

Jamjoom Pharma to participate in 42nd JP Morgan Healthcare Conference

Argaam 10/01/2024

How did analysts view TASI performance, top picks for 2024?

Argaam Special 09/01/2024

Al Rajhi Capital issues Q4 2023 earnings forecasts

Argaam Special 08/01/2024

United Securities previews Q4 2023 earnings for Saudi firms

Argaam Special 07/01/2024

Al Rajhi Capital expects TASI to hit 12,647 pts, names top picks

Argaam 07/01/2024

Trading ban on Jamjoom Pharma’s major shareholders ends today

Argaam 19/12/2023

How did analysts view Jamjoom Pharma’s Q3 financials?

Argaam Special 05/12/2023

GIB Capital sets rating for Jamjoom Pharma

Argaam 03/12/2023

Al Rajhi Capital says Saudi pharmaceuticals sector poised for growth; sets recommendations, TP

Argaam 23/11/2023

Jamjoom Pharma offers SAR 18.5M corporate guarantee for Algeria JV

Argaam 22/11/2023

MSCI adds 1 fund, 2 firms to Small Cap Index

Argaam 15/11/2023

Jamjoom Pharma to disclose 9M 2023 results on Nov. 7

Argaam 01/11/2023

Al Rajhi Capital issues Q3 profit forecasts for Saudi-listed companies

Argaam Special 05/10/2023

TASI leaps 5.5% in 9M 2023; Etihad Atheeb, Elm top gainers

ِArgaam special 30/09/2023

Tadawul announces indices maintenance for Q3 2023

Argaam 25/09/2023

Jamjoom Pharma revises up 2023 guidance

Argaam Special 10/08/2023

Jamjoom Pharma board OKs 10% dividend for H1 2023

ِArgaam 10/08/2023

Jamjoom Pharma to raise capital of its Algeria joint venture

Argaam 31/07/2023

Jamjoom Pharma targets 17% revenue growth, higher profit margin in 2023: CEO

Argaam Special 11/07/2023

Al Rajhi Capital issues Q2 earnings estimates

ِArgaam 10/07/2023

Al Rajhi Capital begins coverage of Saudi pharma sector, assigns ratings

Argaam 05/07/2023

GIB Capital initiates coverage on Jamjoom Pharma

ِArgaam 20/06/2023

Jamjoom Pharma to debut on Tadawul today

Argaam Special 20/06/2023

Jamjoom Pharma shares to debut on Tadawul on June 20

Argaam 18/06/2023

Edaa deposits Jamjoom Pharma securities into shareholder accounts

Argaam 15/06/2023

Jamjoom Pharma retail IPO 11x covered, 4 shares allotted per subscriber

Argaam 06/06/2023

Retail subscription to 2.1 mln shares of Jamjoom Pharma IPO starts today

Argaam Special 30/05/2023

Jamjoom Pharma IPO: subscription period, key dates

Argaam 30/05/2023

Here’s a list of receiving banks for Jamjoon Pharma IPO

Argaam 30/05/2023

Jamjoom Pharma sets IPO final price at SAR 60/share

Argaam 25/05/2023

Al Mawarid, Morabaha Marina, Jamjoom compliant with Shariah: Albilad Capital

Argaam 23/05/2023

Jamjoom Pharma sets IPO price range between 56-60/share

Argaam 15/05/2023

Jamjoom Pharma allocates 5.17 mln shares to cornerstone investors

Argaam 14/05/2023

Jamjoom Pharma issues prospectus to offer 21 mln shares on Tadawul

Argaam 04/05/2023

Jamjoom Pharma gets CMA nod to offer 21 mln shares on Tadawul

Argaam 28/12/2022